Are you betting on Oracle or Synopsys?

Are you betting on Oracle or Synopsys?

By Trefis Team
Publication Date: 2025-12-09 15:40:00

Synopsys is up 18% in the last month. You may be considering whether you want to buy more shares or reduce your investment. However, there is a completely different point of view that you may not have considered. Could there be a better option? It turns out that its competitor Oracle offers more advantages. Oracle (ORCL) Stocks offer better revenue growth, higher profitability and comparatively lower valuation than during critical periods Summary (SNPS) stocks, indicating that you may prefer to invest in ORCL. See also, Buy or sell Salesforce shares?

  • ORCL’s revenue growth in the last 12 months was…